CD274 and cancer: When combined with anti-PD-L1 antibody, the DNA vaccine induced robust antitumor response in preclinical models (Li et al., 2021)Moreover, nanotechnology has also contributed a lot to designing multicomponent and multivalent cancer vaccines, and we refer readers to these reviews (Li et al., 2022; Lim et al., 2020).